|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.1600 - 1.2000|
|52 Week Range||0.4890 - 2.9200|
|Beta (5Y Monthly)||1.86|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 12, 2021 - Aug. 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that it has received a cash distribution of approximately $6.5 million and that termination of PharmHouse Inc.'s ("PharmHouse") proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA Proceedings") and PharmHouse's assignment into bankruptcy under the Bankruptcy and Insolvency Act (Canada) is expected imminently. Pursuant to orders granted by the Ontario Superior Court of Justice (Com
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 30, 2021 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's profile on the System for Electronic Document Analysis and Retrieval or on its website at www.rivcapital.com/investors.
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) is pleased to announce the completion of the previously announced purchase by The Hawthorne Collective, Inc. ("The Hawthorne Collective"), a cannabis-focused subsidiary of The Scotts Miracle-Gro Company (NYSE: SMG) ("ScottsMiracle-Gro"), of an unsecured convertible note (the "Convertible Note") from RIV Capital for US$150 million (the "Investment").